Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 27.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000602 | Hanako Sekimukai [Japon] ; Naoko Iwata-Yoshikawa [Japon] ; Shuetsu Fukushi [Japon] ; Hideki Tani [Japon] ; Michiyo Kataoka [Japon] ; Tadaki Suzuki [Japon] ; Hideki Hasegawa [Japon] ; Kenichi Niikura [Japon] ; Katsuhiko Arai [Japon] ; Noriyo Nagata [Japon] | Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. |
| 001045 | Yutaro Yamaoka [Japon] ; Shutoku Matsuyama [Japon] ; Shuetsu Fukushi [Japon] ; Satoko Matsunaga [Japon] ; Yuki Matsushima [Japon] ; Hiroyuki Kuroyama [Japon] ; Hirokazu Kimura [Japon] ; Makoto Takeda [Japon] ; Tomoyuki Chimuro [Japon] ; Akihide Ryo [Japon] | Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen. |
| 002A67 | Koji Ishii [Japon] ; Hideki Hasegawa ; Noriyo Nagata ; Yasushi Ami ; Shuetsu Fukushi ; Fumihiro Taguchi ; Yasuko Tsunetsugu-Yokota | Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model. |
| 003050 | Shuetsu Fukushi [Japon] ; Rie Watanabe ; Fumihiro Taguchi | Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins. |
| 003116 | Rie Watanabe [Japon] ; Shutoku Matsuyama ; Kazuya Shirato ; Masami Maejima ; Shuetsu Fukushi ; Shigeru Morikawa ; Fumihiro Taguchi | Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein. |
| 003403 | Yasushi Ami [Japon] ; Noriyo Nagata [Japon] ; Kazuya Shirato [Japon] ; Rie Watanabe [Japon] ; Naoko Iwata [Japon] ; Keiko Nakagaki [Japon] ; Shuetsu Fukushi [Japon] ; Masayuki Saijo [Japon] ; Shigeru Morikawa [Japon] ; Fumihiro Taguchi [Japon] | Co‐infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in mice |
| 003486 | Noriyo Nagata [Japon] ; Naoko Iwata [Japon] ; Hideki Hasegawa [Japon] ; Shuetsu Fukushi [Japon] ; Ayako Harashima [Japon] ; Yuko Sato [Japon] ; Masayuki Saijo [Japon] ; Fumihiro Taguchi [Japon] ; Shigeru Morikawa [Japon] ; Tetsutaro Sata [Japon] | Mouse-Passaged Severe Acute Respiratory Syndrome-Associated Coronavirus Leads to Lethal Pulmonary Edema and Diffuse Alveolar Damage in Adult but Not Young Mice |
| 003505 | Rie Watanabe [Japon] ; Shutoku Matsuyama [Japon] ; Kazuya Shirato [Japon] ; Masami Maejima [Japon] ; Shuetsu Fukushi [Japon] ; Shigeru Morikawa [Japon] ; Fumihiro Taguchi [Japon] | Entry from the Cell Surface of Severe Acute Respiratory Syndrome Coronavirus with Cleaved S Protein as Revealed by Pseudotype Virus Bearing Cleaved S Protein |
| 003B21 | Masahiro Ikejiri [Japon] ; Masayuki Saijo [Japon] ; Shigeru Morikawa [Japon] ; Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Ichiro Kurane [Japon] ; Tokumi Maruyama [Japon] | Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents |
| 003B48 | Noriyo Nagata [Japon] ; Naoko Iwata [Japon] ; Hideki Hasegawa [Japon] ; Shuetsu Fukushi [Japon] ; Masaru Yokoyama [Japon] ; Ayako Harashima [Japon] ; Yuko Sato [Japon] ; Masayuki Saijo [Japon] ; Shigeru Morikawa [Japon] ; Tetsutaro Sata [Japon] | Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 Rats infected with SARS coronavirus |
| 003B89 | Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Kouji Sakai [Japon] ; Masayuki Saijo [Japon] ; Fumihiro Taguchi [Japon] ; Masaru Yokoyama [Japon] ; Ichiro Kurane [Japon] ; Shigeru Morikawa [Japon] | Amino acid substitutions in the S2 region enhance severe acute respiratory syndrome coronavirus infectivity in rat angiotensin-converting enzyme 2-expressing cells |
| 003D48 | Tetsuya Mizutani [Japon] ; Shuetsu Fukushi ; Masayuki Saijo ; Ichiro Kurane ; Shigeru Morikawa | Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells. |
| 003D64 | Shuetsu Fukushi [Japon] ; Tetsuya Mizutani ; Masayuki Saijo ; Shutoku Matsuyama ; Fumihiro Taguchi ; Ichiro Kurane ; Shigeru Morikawa | Pseudotyped vesicular stomatitis virus for functional analysis of SARS coronavirus spike protein. |
| 003E23 | Tetsuya Mizutani [Japon] ; Shuetsu Fukushi ; Koji Ishii ; Yuko Sasaki ; Tsuyoshi Kenri ; Masayuki Saijo ; Yumi Kanaji ; Kinji Shirota ; Ichiro Kurane ; Shigeru Morikawa | Mechanisms of establishment of persistent SARS-CoV-infected cells. |
| 003E62 | Aya Zamoto [Japon] ; Fumihiro Taguchi ; Shuetsu Fukushi ; Shigeru Morikawa ; Yasuko K. Yamada | Identification of ferret ACE2 and its receptor function for SARS-coronavirus. |
| 003F07 | Shutoku Matsuyama [Japon] ; Makoto Ujike ; Koji Ishii ; Shuetsu Fukushi ; Shigeru Morikawa ; Masato Tashiro ; Fumihiro Taguchi | Enhancement of SARS-CoV infection by proteases. |
| 003F58 | Tetsuya Mizutani [Japon] ; Shuetsu Fukushi ; Masayuki Saijo ; Ichiro Kurane | Characterization of persistent SARS-CoV infection in Vero E6 cells. |
| 003F80 | Masahiro Ikejiri [Japon] ; Masayuki Saijo ; Shigeru Morikawa ; Shuetsu Fukushi ; Tetsuya Mizutani ; Ichiro Kurane ; Tokumi Maruyama | Anti-SARS-CoV activity of nucleoside analogs having 6-chloropurine as a nucleobase. |
| 004285 | Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Masayuki Saijo [Japon] ; Ichiro Kurane [Japon] ; Fumihiro Taguchi [Japon] ; Masato Tashiro [Japon] ; Shigeru Morikawa [Japon] | Evaluation of a novel vesicular stomatitis virus pseudotype‐based assay for detection of neutralizing antibody responses to SARS‐CoV |
| 004438 | Tetsuya Mizutani [Japon] ; Shuetsu Fukushi [Japon] ; Daisuke Lizuka [Japon] ; Osamu Inanami [Japon] ; Mikinori Kuwabara [Japon] ; Hideaki Takashima [Japon] ; Hiroshi Yanagawa [Japon] ; Masayuki Saijo [Japon] ; Ichiro Kurane [Japon] ; Shigeru Morikawa [Japon] | Inhibition of cell proliferation by SARS-CoV infection in Vero E6 cells |
| 004681 | Masayuki Saijo [Japon] ; Toshio Ogino ; Fumihiro Taguchi ; Shuetsu Fukushi ; Tetsuya Mizutani ; Tsugunori Notomi ; Hidetoshi Kanda ; Harumi Minekawa ; Shutoku Matsuyama ; Hoang Thuy Long ; Nguyen Thi Hong Hanh ; Ichiro Kurane ; Masato Tashiro ; Shigeru Morikawa | Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS. |
| 004777 | Tetsuya Mizutani [Japon] ; Shuetsu Fukushi ; Masayuki Saijo ; Ichiro Kurane ; Shigeru Morikawa | JNK and PI3k/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells. |
| 004D30 | Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Masayuki Saijo [Japon] ; Shutoku Matsuyama [Japon] ; Naoko Miyajima [Japon] ; Fumihiro Taguchi [Japon] ; Shigeyuki Itamura [Japon] ; Ichiro Kurane [Japon] ; Shigeru Morikawa [Japon] | Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein |
| 004E02 | Masayuki Saijo [Japon] ; Shigeru Morikawa [Japon] ; Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Hideki Hasegawa [Japon] ; Noriyo Nagata [Japon] ; Naoko Iwata [Japon] ; Ichiro Kurane [Japon] | Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus |
| 004F93 | Tetsuya Mizutani [Japon] ; Shuetsu Fukushi ; Masaaki Murakami ; Toshio Hirano ; Masayuki Saijo ; Ichiro Kurane ; Shigeru Morikawa | Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells. |
| 005214 | Tetsuya Mizutani [Japon] ; Shuetsu Fukushi ; Masayuki Saijo ; Ichiro Kurane ; Shigeru Morikawa | Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells. |
| 005297 | Tetsuya Mizutani [Japon] ; Shuetsu Fukushi ; Masayuki Saijo ; Ichiro Kurane ; Shigeru Morikawa | Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cells. |
| This area was generated with Dilib version V0.6.33. |  |